Fine Foods & Pharmaceuticals N.T.M. SpA(IT:FF)
€5.44-0.56 (-11.69%)
IT:FF
Fine Foods & Pharmaceuticals N.T.M. SpA financials statements
€5.44
At close:-0.56 (-11.69%)
Want to see IT:FF full AI Analyst Report?
Fine Foods & Pharmaceuticals N.T.M. SpA (FF) Ratios
7 Followers
Fine Foods & Pharmaceuticals N.T.M. SpA Ratios
IT:FF's free cash flow for Q2 2026 was €-46.35K. For the 2026 fiscal year, IT:FF's free cash flow was decreased by €-7.01M and operating cash flow was €6.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.75 | 1.36 | 1.10 | 1.96 | 1.56 |
| Quick Ratio | 1.23 | 0.91 | 0.68 | 1.48 | 1.24 |
| Cash Ratio | 0.58 | 0.27 | 0.19 | 0.12 | 0.16 |
| Solvency Ratio | 0.19 | 0.22 | 0.11 | 0.04 | 0.08 |
| Operating Cash Flow Ratio | 0.47 | 0.65 | 0.18 | 0.04 | -0.05 |
| Short-Term Operating Cash Flow Coverage | 2.49 | 2.50 | 0.34 | 0.09 | -0.09 |
| Net Current Asset Value | € -28.47M | € -14.10M | € -3.20M | € -1.86M | € 15.96M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.22 | 0.27 | 0.40 | 0.37 |
| Debt-to-Equity Ratio | 0.65 | 0.41 | 0.52 | 0.90 | 0.75 |
| Debt-to-Capital Ratio | 0.39 | 0.29 | 0.34 | 0.47 | 0.43 |
| Long-Term Debt-to-Capital Ratio | 0.35 | 0.21 | 0.07 | 0.37 | 0.21 |
| Financial Leverage Ratio | 2.09 | 1.84 | 1.90 | 2.25 | 2.06 |
| Debt Service Coverage Ratio | 1.89 | 1.25 | 0.29 | 0.20 | 0.19 |
| Interest Coverage Ratio | 5.02 | 4.32 | 0.21 | -0.73 | 7.44 |
| Debt to Market Cap | 0.35 | 0.28 | 0.30 | 0.57 | 0.29 |
| Interest Debt Per Share | 3.51 | 2.27 | 2.84 | 5.00 | 4.67 |
| Net Debt to EBITDA | 1.44 | 1.14 | 2.46 | 30.27 | 9.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 14.05% | 32.87% | 27.22% | 25.93% | 28.75% |
| EBIT Margin | 6.07% | 6.21% | 1.25% | -5.71% | -1.82% |
| EBITDA Margin | 13.21% | 12.68% | 7.66% | 1.76% | 5.07% |
| Operating Profit Margin | 6.07% | 6.01% | 0.42% | -0.85% | 4.01% |
| Pretax Profit Margin | 5.38% | 4.85% | -0.74% | -6.86% | -2.36% |
| Net Profit Margin | 4.01% | 3.35% | -1.40% | -4.59% | -0.73% |
| Continuous Operations Profit Margin | 4.01% | 3.35% | -1.40% | -4.59% | -0.73% |
| Net Income Per EBT | 74.41% | 68.93% | 189.87% | 66.91% | 31.09% |
| EBT Per EBIT | 88.75% | 80.80% | -174.02% | 810.91% | -58.85% |
| Return on Assets (ROA) | 3.61% | 3.36% | -1.46% | -3.17% | -0.47% |
| Return on Equity (ROE) | 7.52% | 6.18% | -2.77% | -7.13% | -0.97% |
| Return on Capital Employed (ROCE) | 7.19% | 8.52% | 0.76% | -0.81% | 4.04% |
| Return on Invested Capital (ROIC) | 5.04% | 5.30% | 0.54% | -0.46% | 0.92% |
| Return on Tangible Assets | 3.79% | 3.55% | -1.54% | -3.37% | -0.50% |
| Earnings Yield | 4.12% | 4.25% | -1.60% | -4.64% | -0.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.88 | 6.38 | 6.51 | 5.14 | 6.44 |
| Payables Turnover | 5.96 | 4.49 | 5.69 | 4.58 | 4.29 |
| Inventory Turnover | 6.20 | 5.15 | 4.34 | 3.79 | 3.98 |
| Fixed Asset Turnover | 1.71 | 1.89 | 2.29 | 1.89 | 1.79 |
| Asset Turnover | 0.90 | 1.00 | 1.04 | 0.69 | 0.64 |
| Working Capital Turnover Ratio | 6.64 | 13.62 | 5.55 | 2.90 | 3.15 |
| Cash Conversion Cycle | 50.72 | 46.84 | 76.04 | 87.60 | 63.29 |
| Days of Sales Outstanding | 53.08 | 57.17 | 56.04 | 70.99 | 56.70 |
| Days of Inventory Outstanding | 58.89 | 70.92 | 84.19 | 96.29 | 91.69 |
| Days of Payables Outstanding | 61.25 | 81.25 | 64.18 | 79.68 | 85.11 |
| Operating Cycle | 111.97 | 128.09 | 140.23 | 167.29 | 148.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.24 | 1.79 | 0.74 | 0.15 | -0.24 |
| Free Cash Flow Per Share | -0.11 | 0.44 | -0.01 | -0.50 | -0.91 |
| Dividend Paid and CapEx Coverage Ratio | 0.83 | 1.22 | 0.87 | 0.19 | -0.30 |
| Capital Expenditure Coverage Ratio | 0.92 | 1.32 | 0.98 | 0.23 | -0.37 |
| Operating Cash Flow Coverage Ratio | 0.37 | 0.84 | 0.28 | 0.03 | -0.05 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.19 | 0.07 | 0.02 | -0.03 |
| Free Cash Flow Yield | -1.17% | 5.80% | -0.15% | -6.01% | -5.90% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.95 | 23.44 | -62.43 | -21.54 | -258.37 |
| Price-to-Sales (P/S) Ratio | 0.97 | 0.79 | 0.87 | 0.99 | 1.90 |
| Price-to-Book (P/B) Ratio | 1.82 | 1.45 | 1.73 | 1.54 | 2.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -85.45 | 17.24 | -666.81 | -16.64 | -16.95 |
| Price-to-Operating Cash Flow Ratio | 7.71 | 4.18 | 11.86 | 55.48 | -63.28 |
| Price-to-Earnings Growth (PEG) Ratio | 0.96 | -0.07 | 1.00 | -0.04 | 2.34 |
| Enterprise Value Multiple | 8.79 | 7.35 | 13.86 | 86.52 | 46.89 |
| Enterprise Value | 292.79M | 227.02M | 267.27M | 314.78M | 462.34M |
| EV to EBITDA | 8.79 | 7.35 | 13.86 | 86.52 | 46.89 |
| EV to Sales | 1.16 | 0.93 | 1.06 | 1.52 | 2.38 |
| EV to Free Cash Flow | -102.16 | 20.41 | -810.53 | -25.60 | -21.26 |
| EV to Operating Cash Flow | 9.22 | 4.95 | 14.42 | 85.34 | -79.35 |
| Tangible Book Value Per Share | 4.72 | 4.66 | 4.52 | 4.71 | 5.37 |
| Shareholders’ Equity Per Share | 5.25 | 5.17 | 5.05 | 5.43 | 6.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.31 | -0.90 | 0.33 | 0.69 |
| Revenue Per Share | 9.86 | 9.54 | 10.01 | 8.43 | 8.12 |
| Net Income Per Share | 0.39 | 0.32 | -0.14 | -0.39 | -0.06 |
| Tax Burden | 0.74 | 0.69 | 1.90 | 0.67 | 0.31 |
| Interest Burden | 0.89 | 0.78 | -0.59 | 1.20 | 1.30 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.02 | 0.02 | 0.12 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 3.15 | 5.62 | -5.26 | -0.39 | 4.08 |
Currency in EUR
